ISIS Pharmaceuticals announced Friday that the company is changing its name to Ionis Pharmaceuticals.
The California-based biotech company will trade on the Nasdaq under the new ticker symbol “IONS,” replacing “ISIS,” according to CNBC.
The company did not cite the Islamic State of Iraq and Greater Syria, commonly known as ISIS, as the reason for the change in a statement issued by chief operating officer Lynne Parshall.
“Our goal is to create medicines that will save patients’ lives, and we are proud to be at the forefront of creating innovative medicines,” Parshall wrote in a statement. “We decided to change our company name because, when people see or hear our name, we want them to think about the life-saving medicines we are developing.”
More Must-Reads From TIME
- The 100 Most Influential People of 2024
- How Far Trump Would Go
- Scenes From Pro-Palestinian Encampments Across U.S. Universities
- Saving Seconds Is Better Than Hours
- Why Your Breakfast Should Start with a Vegetable
- 6 Compliments That Land Every Time
- Welcome to the Golden Age of Ryan Gosling
- Want Weekly Recs on What to Watch, Read, and More? Sign Up for Worth Your Time
Contact us at letters@time.com